Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment
Public ClinicalTrials.gov record NCT00343811. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-week, Double-Blind, Placebo-Controlled, Parallel Group Randomized Withdrawal Study to Evaluate the Continued Efficacy of Modafinil Treatment in Dosages up to 425mg/Day in Patients With Attention-Deficit/Hyperactivity Disorder Who Are Responders to Modafinil Treatment, Followed by a 12-Month Open-Label Extension Period
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the continued efficacy of modafinil treatment, compared to placebo treatment, in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who are responders to modafinil treatment.
Study identification
- NCT ID
- NCT00343811
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2006 (Type not available)
- Primary completion
- Not listed
- Completion
- Sep 2006 (Actual)
- Last update posted
- May 9, 2014
2006
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Study Centers, LLC | Little Rock | Arkansas | 72205 | — |
| UCI Child Development Center | Irvine | California | 92612 | — |
| University of California at San Francisco | San Francisco | California | 94143 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Alpine Clinical Research | Boulder | Colorado | 80304 | — |
| Sarkis Family Psychiatry | Gainesville | Florida | 32607 | — |
| Amedica Research Institute, Inc. | Hialeah | Florida | 33013 | — |
| Miami Research Associates | Miami | Florida | 33173 | — |
| Child Neurology Associates | Atlanta | Georgia | 30342 | — |
| Kentucky Pediatric/Adult Research | Bardstown | Kentucky | 40004 | — |
| Michael J. Rieser, MD, PSC | Lexington | Kentucky | 40509 | — |
| Four Rivers Clinical Research, Inc. | Paducah | Kentucky | 42001 | — |
| Clinical Neurophysiology Services | Troy | Michigan | 48085 | — |
| University of Nebraska | Omaha | Nebraska | 68198 | — |
| CNS Research Institute | Clementon | New Jersey | 08021 | — |
| Piedmont Neuropsychiatry | Charlotte | North Carolina | 28226 | — |
| Triangle Neuropsychiatry | Durham | North Carolina | 27717 | — |
| Pahl Pharmaceutical Research, Inc. | Oklahoma City | Oklahoma | 73118 | — |
| OCCI, Inc. | Salem | Oregon | 97301 | — |
| The Clinical Study Center | Burlington | Vermont | 05401 | — |
| Monarch Research Associates | Norfolk | Virginia | 23510 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
| Pacific Institute Mental Health | Seattle | Washington | 98133 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00343811, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2014 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00343811 live on ClinicalTrials.gov.